SCHEMBL17370004

SCHEMBL17370004

c1ccc(N(c2cc(N(c3ccccc3)c3ccc4oc5ccccc5c4c3)cc(N(c3ccccc3)c3cccc4c3oc3ccccc34)c2)c2ccc3oc4ccccc4c3c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.39
NPC1 O15118 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
RAB9A P51151 1/20 0.39
AHR P35869 3/20 0.36
ALOX5 P09917 3/20 0.35
LMNA P02545 2/20 0.34
CYP1A2 P05177 2/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
KEAP1 Q14145 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TTR P02766 1/20 0.31
MAOA P21397 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17369939 1.00 MAPT (0.39) MAPTNPC1KDM4EMEN1ALDH1A1
SCHEMBL24700783 0.97 MAPT (0.41) MAPTNPC1KDM4EMEN1ALDH1A1
SCHEMBL15964368 0.96 MAPT (0.41) MAPTNPC1KDM4EMEN1ALDH1A1
SCHEMBL17369906 0.95 ALOX5 (0.37) MAPTNPC1KDM4EMEN1ALDH1A1
SCHEMBL21966506 0.94 MAPT (0.38) MAPTNPC1KDM4EMEN1ALDH1A1
SCHEMBL22506123 0.94 MAPT (0.38) MAPTNPC1KDM4EMEN1ALDH1A1
SCHEMBL14295723 0.94 ALOX5 (0.39) MAPTNPC1KDM4EMEN1ALDH1A1
SCHEMBL21966510 0.94 MAPT (0.38) MAPTNPC1KDM4EMEN1ALDH1A1
SCHEMBL15730674 0.93 ALOX5 (0.39) MAPTNPC1KDM4EMEN1ALDH1A1
SCHEMBL16482310 0.93 MAPT (0.34) MAPTNPC1KDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10381571-B2 Compound, organic light emitting element comprising same, and display device comprising organic light emitting element SAMSUNG SDI CO., LTD. (KR) 2019-08-13 US disclosed
US-20150380659-A1 COMPOUND, ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME, AND DISPLAY DEVICE COMPRISING ORGANIC LIGHT EMITTING ELEMENT SAMSUNG SDI CO., LTD. (KR) 2015-12-31 US disclosed
US-20150380659-A1 COMPOUND, ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME, AND DISPLAY DEVICE COMPRISING ORGANIC LIGHT EMITTING ELEMENT SAMSUNG SDI CO., LTD. (KR) 2015-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10381571-B2 Compound, organic light emitting element comprising same, and display device comprising organic light emitting element OR51E2, OR10J3, AOX1 MAPT 1647/4885NPC1 2266/4885KDM4E 3284/4885
US-20150380659-A1 COMPOUND, ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME, AND DISPLAY DEVICE COMPRISING ORGANIC LIGHT EMITTING ELEMENT OR51E2, OR10J3, AOX1 MAPT 1647/4885NPC1 2266/4885KDM4E 3284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.